886779-69-7 Usage
Uses
Used in Pharmaceutical Research:
3-Trifluoromethyl-piperazine-1-carboxylic acid tert-butyl ester is used as a building block in organic synthesis and pharmaceutical research for its potential to develop new drugs. Its interaction with biological targets in the central nervous system makes it a promising candidate for the treatment of various neurological disorders.
Used in Medicinal Chemistry Studies:
In the field of medicinal chemistry, 3-Trifluoromethyl-piperazine-1-carboxylic acid tert-butyl ester is utilized as a valuable compound for enhancing the pharmacokinetic properties of drug molecules. The trifluoromethyl group in its structure contributes to improved drug delivery and efficacy, making it an essential component in the design and synthesis of novel therapeutic agents.
Used in Organic Synthesis:
3-Trifluoromethyl-piperazine-1-carboxylic acid tert-butyl ester is employed as a key intermediate in the synthesis of various organic compounds. Its unique structure and functional groups make it a versatile building block for the development of new chemical entities with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 886779-69-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,7,7 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 886779-69:
(8*8)+(7*8)+(6*6)+(5*7)+(4*7)+(3*9)+(2*6)+(1*9)=267
267 % 10 = 7
So 886779-69-7 is a valid CAS Registry Number.
886779-69-7Relevant articles and documents
NOVEL TRIAZOLONE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Paragraph 662; 663; 664, (2014/11/13)
The present invention provides a triazolone derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The triazolone derivative or its pharmaceutically acceptable salt can effectively activate GPR119; and therefore be usefully applied for preventing or treating diabetes mellitus.
